Abstract
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB) is a critical pathogen associated with severe hospital infections and high antimicrobial resistance. Despite the global significance of A. baumannii, there are limited data from Costa Rica regarding the resistance rate and genomic characteristics of CRAB. Methods: This study aimed to provide initial and exploratory epidemiological data on infections caused by A. baumannii and CRAB isolated in Costa Rica and to gain insights on the genome of selected strains, focusing on their resistance determinants and phylogenetic relationships. Results: Based on data from five main hospitals in Costa Rica, resistance rate to carbapenems was estimated at 9.8% to imipenem and 6.1% to meropenem. From 190 carbapenem-resistant clinical isolates available in a local collection, seven A. baumannii strains were identified, all showing resistance to carbapenems and carrying the bla(NDM-1) gene. Whole-genome sequencing of two strains yielded two distinct MLST profiles (Pasteur scheme: ST-150 for strain IPAT15 and ST-250 for IPAT72), as well as variations in the number and identity of plasmids, genomic islands, and other elements of the mobilome. Both isolates carried ten antimicrobial resistance genes, which are predicted to be harbored in plasmids for IPAT15, unlike the chromosomal determinants in IPAT72. A pangenome analysis of 878 genomes from a public database identified over 51,000 genes, with only 1338 (2.6%) forming the core genome. Phylogenetic analysis and assignation of international clones (ICs) showed predominance of IC2. Isolates from Costa Rica clustered near IC9 and shared some resistance determinants, but they were not directly assigned to an IC. Conclusions: Overall, this study provides exploratory insights regarding the occurrence of CRAB in Costa Rica using epidemiological and genomic data, with profiles that are comparable to other regions in Latin America and diverse genomic resistance determinants. While this study does not show the whole landscape of CRAB in Costa Rica, these data constitute an initial approach for improving clinical management and public health responses to CRAB infections, to ultimately improve outcomes for patients affected by this pathogen.